Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions
View ORCID ProfileJack Wilkinson, Calvin Heal, George A. Antoniou, Ella Flemyng, Zarko Alfirevic, Alison Avenell, Virginia Barbour, Nicholas J L Brown, John Carlisle, Mike Clarke, Patrick Dicker, Jo Dumville, Andrew Grey, Steph Grohmann, Lyle C Gurrin, Jill A Hayden, James Heathers, Kylie E Hunter, Toby Lasserson, Emily Lam, Sarah Lensen, Tianjing Li, Wentao Li, Elizabeth Loder, Andreas Lundh, Gideon Meyerowitz-Katz, Ben W Mol, Neil E O’Connell, Lisa Parker, Barbara K. Redman, Anna Lene Seidler, Kyle A Sheldrick, Emma Sydenham, David J Torgerson, Madelon van Wely, Rui Wang, Lisa Bero, View ORCID ProfileJamie J Kirkham
doi: https://doi.org/10.1101/2023.09.21.23295626
Jack Wilkinson
1Centre for Biostatistics, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
Calvin Heal
1Centre for Biostatistics, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
George A. Antoniou
2Manchester Vascular Centre, Manchester University NHS Foundation Trust, Manchester, UK
3Division of Cardiovascular Sciences, School of Medical Sciences, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK
Ella Flemyng
4Evidence Production and Methods Directorate, Cochrane Central Executive, London, UK
Zarko Alfirevic
5Emeritus Professor, University of Liverpool, UK
Alison Avenell
6Health Services Research Unit, University of Aberdeen, UK
Virginia Barbour
7Medical Journal of Australia, Sydney, Australia
Nicholas J L Brown
8Department of Psychology, Linnaeus University, Växjö, Sweden
John Carlisle
9Perioperative Medicine, Torbay hospital, UK
Mike Clarke
10Department of Epidemiology and Public Health, Royal College of Surgeons in Ireland
Patrick Dicker
11Northern Ireland Methodology Hub, Queen’s University Belfast, Northern Ireland
Jo Dumville
12Division of Nursing, Midwifery & Social Work, School of Health Sciences, The University of Manchester, Manchester, UK
13NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
Andrew Grey
14Department of Medicine, University of Auckland, Auckland, New Zealand
Steph Grohmann
4Evidence Production and Methods Directorate, Cochrane Central Executive, London, UK
Lyle C Gurrin
15School of Population and Global Health, The University of Melbourne, Australia
Jill A Hayden
16Department of Community Health & Epidemiology, Faculty of Medicine, Dalhousie University, Canada
James Heathers
17SafeBeat Rx Inc, USA
Kylie E Hunter
18Evidence Integration, NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia
Toby Lasserson
4Evidence Production and Methods Directorate, Cochrane Central Executive, London, UK
Emily Lam
19Independent lay member, unaffiliated, Cheshire, UK
Sarah Lensen
20Department of Obstetrics and Gynaecology, Royal Women’s Hospital, University of Melbourne, Melbourne, Australia
Tianjing Li
21Department of Ophthalmology, University of Colorado Anschutz Medical Campus
Wentao Li
22Department of Obstetrics and Gynaecology, Monash University, VIC, Australia
Elizabeth Loder
23The BMJ, London, UK
24Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA
Andreas Lundh
25Cochrane Denmark & Centre for Evidence-Based Medicine Odense, Department of Clinical Research, University of Southern Denmark, Denmark
26Department of Respiratory Medicine and Infectious Diseases, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark
Gideon Meyerowitz-Katz
27School of Health and Society, University of Wollongong, Wollongong, Australia
Ben W Mol
28Monash University, Clayton, Victoria, Australia
29Aberdeen Centre for Women’s Health Research, University of Aberdeen, Aberdeen, UK
Neil E O’Connell
30Centre for Health and Wellbeing across the Lifecourse, Dept of Health Sciences, Brunel University London, UK
Lisa Parker
31School of Pharmacy, Charles Perkins Centre, The University of Sydney, Australia
Barbara K. Redman
32Division of Medical Ethics, New York University Grossman School of Medicine, New York, NY
Anna Lene Seidler
18Evidence Integration, NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia
Kyle A Sheldrick
33Faculty of Medicine, University of New South Wales, Australia
Emma Sydenham
34Cochrane Central Production Service, UK
David J Torgerson
35York Trials Unit, Dept of Health Sciences, University of York, UK
Madelon van Wely
36Cochrane Gynaecology and Fertility Satellite and Cochrane Sexually Transmitted Infection Group, Amsterdam
37Reproduction and Development Research Institute, Amsterdam University Medical Center, The Netherlands
Rui Wang
22Department of Obstetrics and Gynaecology, Monash University, VIC, Australia
Lisa Bero
38University of Colorado Anschutz Medical Campus, Colorado, USA
Jamie J Kirkham
1Centre for Biostatistics, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
This is a research protocol. Datasets arising from the project will be made freely available.
Posted November 13, 2023.
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions
Jack Wilkinson, Calvin Heal, George A. Antoniou, Ella Flemyng, Zarko Alfirevic, Alison Avenell, Virginia Barbour, Nicholas J L Brown, John Carlisle, Mike Clarke, Patrick Dicker, Jo Dumville, Andrew Grey, Steph Grohmann, Lyle C Gurrin, Jill A Hayden, James Heathers, Kylie E Hunter, Toby Lasserson, Emily Lam, Sarah Lensen, Tianjing Li, Wentao Li, Elizabeth Loder, Andreas Lundh, Gideon Meyerowitz-Katz, Ben W Mol, Neil E O’Connell, Lisa Parker, Barbara K. Redman, Anna Lene Seidler, Kyle A Sheldrick, Emma Sydenham, David J Torgerson, Madelon van Wely, Rui Wang, Lisa Bero, Jamie J Kirkham
medRxiv 2023.09.21.23295626; doi: https://doi.org/10.1101/2023.09.21.23295626
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions
Jack Wilkinson, Calvin Heal, George A. Antoniou, Ella Flemyng, Zarko Alfirevic, Alison Avenell, Virginia Barbour, Nicholas J L Brown, John Carlisle, Mike Clarke, Patrick Dicker, Jo Dumville, Andrew Grey, Steph Grohmann, Lyle C Gurrin, Jill A Hayden, James Heathers, Kylie E Hunter, Toby Lasserson, Emily Lam, Sarah Lensen, Tianjing Li, Wentao Li, Elizabeth Loder, Andreas Lundh, Gideon Meyerowitz-Katz, Ben W Mol, Neil E O’Connell, Lisa Parker, Barbara K. Redman, Anna Lene Seidler, Kyle A Sheldrick, Emma Sydenham, David J Torgerson, Madelon van Wely, Rui Wang, Lisa Bero, Jamie J Kirkham
medRxiv 2023.09.21.23295626; doi: https://doi.org/10.1101/2023.09.21.23295626
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2600)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12139)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4035)
- Geriatric Medicine (380)
- Health Economics (671)
- Health Informatics (2607)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (833)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3804)
- Nursing (208)
- Nutrition (567)
- Oncology (1991)
- Ophthalmology (578)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1100)
- Primary Care Research (443)
- Public and Global Health (6473)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (52)
- Transplantation (185)
- Urology (165)